AI and blood tests join forces to crack the code of hormone disorders
NCT ID NCT07253454
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will use machine learning and metabolomics (detailed analysis of blood chemicals) to improve diagnosis of hyperandrogenism, a condition causing excess male hormones in women. Researchers will analyze data from 800 women aged 16-45 to better distinguish between common causes like PCOS and rarer genetic conditions. The goal is to create tools that lead to faster, more accurate diagnoses and better management of related health issues like infertility.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to faster, more accurate diagnosis of the cause of hyperandrogenism, helping tailor treatment and reduce infertility.
- What could go wrong
- This is an observational study using existing data, not a treatment trial. The machine learning models may not prove reliable enough for routine clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 800 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2040
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The first stage of the study will involve participating centers selecting patients' medical records after verifying their eligibility. It should be noted that the control group will consist of a population for whom tests were carried out for symptoms that were ultimately ruled out with normal results.
- Ages
-
16 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients of childbearing age (16 to 45 years old) * Suffering from hyperandrogenism * Established etiological diagnosis with elimination of differential diagnoses * Informed and not opposed to the collection of their data for the purposes of the study Exclusion Criteria: * Pregnancy * Patients under legal protection measures
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hyperandrogenism are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.